9 Take-Aways About Digital Health From 2020

Finally, we can say that the surreal year of 2020 is behind us as we welcome a new year rich in potential for digital health and (hopefully) full of good news! Even though the year that went by was dominated with news regarding the novel coronavirus, there were also other important developments in the digital health world; some of which were also shaped by the pandemic. As such, before diving into what lies ahead of this field in 2021, let’s take a step back and contemplate 9 take-aways about digital health from 2020. These can give us further insights into how those relevant trends will shape up in the near future. 1. Proteus failed, but digital pill technology did not In 2017, Proteus made headlines for developing the first-ever FDA-approved digital pill. As recently as 2019, the digital pill pioneer was valued at $1.5 billion. But then in 2020, Proteus filed for bankruptcy. The downfall of this digital health unicorn was attributed to many factors from poor management to overpriced pills. Nevertheless, a company’s downfall doesn’t necessarily mean the downfall of the technology. Indeed, studies showed that digital pills help in improving adherence among populations with adherence issues. Other companies like etectRx and Infármate are also working on digital pills of their own. Otsuka Pharmaceutical, Proteus’ former partner, even acquired the dethroned digital health unicorn; a move that acknowledges the potential of digital pills in pharma....
Source: The Medical Futurist - Category: Information Technology Authors: Tags: 3D Printing Artificial Intelligence in Medicine Digital Health Research E-Patients Future of Medicine Healthcare Design Healthcare Policy Robotics Security & Privacy Telemedicine & Smartphones AI fda smartwatch wearables fitnes Source Type: blogs